1. Libtayo (cemiplimab-rwlc)
    Libtayo (cemiplimab-rwlc)
    by Sanofi
    for Skin Cancer
  2. Eril (fasudil hydrochloride)
    Eril (fasudil hydrochloride)
    by Various
    for Cerebrovascular Disorder
  3. Nuedexta (dextromethorphan HBr and quinidine sulfate)
    Nuedexta (dextromethorphan HBr and quinidine sulfate)
    by Avanir Pharmaceuticals
    for Pseudobulbar Affect (PBA)
  4. Relumina (relugolix)
    Relumina (relugolix)
    by Takeda Pharma A/S
  5. Orilissa (elagolix)
    Orilissa (elagolix)
    by AbbVie Ltd
  6. Takhzyro (lanadelumab)
    Takhzyro (lanadelumab)
    by Shire Pharmaceuticals
    for Hereditary angioedema (HAE)
  7. Cablivi (caplacizumab)
    Cablivi (caplacizumab)
    by Ablynx NV
  8. Lorbrena/Lorviqua (lorlatinib)
    Lorbrena/Lorviqua (lorlatinib)
    by Pfizer Limited
    for Lung Cancer
  9. Kalydeco (ivacaftor)
    Kalydeco (ivacaftor)
    by Vertex Pharmaceuticals (Europe) Ltd
    for Cystic Fibrosis
View as Grid List

Items 1-9 of 72

per page
Set Descending Direction